Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is the second two largest consumption places with the consumption market share of 18% and 17%, respectively.

According to this study, over the next five years the Transforming Growth Factor Beta 1 market will register a 11.3% CAGR in terms of revenue, the global market size will reach US$ 1790 million by 2024, from US$ 1050 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transforming Growth Factor Beta 1 business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.

This study considers the Transforming Growth Factor Beta 1 value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Pirfenidone

Galunisertib

Others

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

IPF

Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Roche

Shionogi Ltd

Acceleron Pharma Inc

Genzyme Corp

Isarna Therapeutics GmbH

Scholar Rock

Sirnaomics Inc

Eli Lilly and Co

Formation Biologics Inc

Novartis AG

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Transforming Growth Factor Beta 1 consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Transforming Growth Factor Beta 1 market by identifying its various subsegments.

Focuses on the key global Transforming Growth Factor Beta 1 manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Transforming Growth Factor Beta 1 with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Transforming Growth Factor Beta 1 submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Transforming Growth Factor Beta 1 Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transforming Growth Factor Beta 1 Consumption 2014-2024

2.1.2 Transforming Growth Factor Beta 1 Consumption CAGR by Region

2.2 Transforming Growth Factor Beta 1 Segment by Type

2.2.1 Pirfenidone

2.2.2 Galunisertib

2.2.3 Others

2.3 Transforming Growth Factor Beta 1 Consumption by Type

2.3.1 Global Transforming Growth Factor Beta 1 Consumption Market Share by Type (2014-2019)

2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2014-2019)

2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2014-2019)

2.4 Transforming Growth Factor Beta 1 Segment by Application

2.4.1 IPF

2.4.2 Cancer

2.4.3 Others

2.5 Transforming Growth Factor Beta 1 Consumption by Application

2.5.1 Global Transforming Growth Factor Beta 1 Consumption Market Share by Application (2014-2019)

2.5.2 Global Transforming Growth Factor Beta 1 Value and Market Share by Application (2014-2019)

2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2014-2019)

3 Global Transforming Growth Factor Beta 1 by Players

3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Players

3.1.1 Global Transforming Growth Factor Beta 1 Sales by Players (2017-2019)

3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Players (2017-2019)

3.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Players

3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Players (2017-2019)

3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Players (2017-2019)

3.3 Global Transforming Growth Factor Beta 1 Sale Price by Players

3.4 Global Transforming Growth Factor Beta 1 Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Transforming Growth Factor Beta 1 Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Transforming Growth Factor Beta 1 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Transforming Growth Factor Beta 1 by Regions

4.1 Transforming Growth Factor Beta 1 by Regions

4.1.1 Global Transforming Growth Factor Beta 1 Consumption by Regions

4.1.2 Global Transforming Growth Factor Beta 1 Value by Regions

4.2 Americas Transforming Growth Factor Beta 1 Consumption Growth

4.3 APAC Transforming Growth Factor Beta 1 Consumption Growth

4.4 Europe Transforming Growth Factor Beta 1 Consumption Growth

4.5 Middle East & Africa Transforming Growth Factor Beta 1 Consumption Growth

5 Americas

5.1 Americas Transforming Growth Factor Beta 1 Consumption by Countries

5.1.1 Americas Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)

5.1.2 Americas Transforming Growth Factor Beta 1 Value by Countries (2014-2019)

5.2 Americas Transforming Growth Factor Beta 1 Consumption by Type

5.3 Americas Transforming Growth Factor Beta 1 Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Transforming Growth Factor Beta 1 Consumption by Countries

6.1.1 APAC Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)

6.1.2 APAC Transforming Growth Factor Beta 1 Value by Countries (2014-2019)

6.2 APAC Transforming Growth Factor Beta 1 Consumption by Type

6.3 APAC Transforming Growth Factor Beta 1 Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Transforming Growth Factor Beta 1 by Countries

7.1.1 Europe Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)

7.1.2 Europe Transforming Growth Factor Beta 1 Value by Countries (2014-2019)

7.2 Europe Transforming Growth Factor Beta 1 Consumption by Type

7.3 Europe Transforming Growth Factor Beta 1 Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Countries

8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Value by Countries (2014-2019)

8.2 Middle East & Africa Transforming Growth Factor Beta 1 Consumption by Type

8.3 Middle East & Africa Transforming Growth Factor Beta 1 Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.2 Transforming Growth Factor Beta 1 Distributors

10.3 Transforming Growth Factor Beta 1 Customer

11 Global Transforming Growth Factor Beta 1 Market Forecast

11.1 Global Transforming Growth Factor Beta 1 Consumption Forecast (2019-2024)

11.2 Global Transforming Growth Factor Beta 1 Forecast by Regions

11.2.1 Global Transforming Growth Factor Beta 1 Forecast by Regions (2019-2024)

11.2.2 Global Transforming Growth Factor Beta 1 Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Transforming Growth Factor Beta 1 Forecast by Type

11.8 Global Transforming Growth Factor Beta 1 Forecast by Application

12 Key Players Analysis

12.1 Roche

12.1.1 Company Details

12.1.2 Transforming Growth Factor Beta 1 Product Offered

12.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Roche News

12.2 Shionogi Ltd

12.2.1 Company Details

12.2.2 Transforming Growth Factor Beta 1 Product Offered

12.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Shionogi Ltd News

12.3 Acceleron Pharma Inc

12.3.1 Company Details

12.3.2 Transforming Growth Factor Beta 1 Product Offered

12.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Acceleron Pharma Inc News

12.4 Genzyme Corp

12.4.1 Company Details

12.4.2 Transforming Growth Factor Beta 1 Product Offered

12.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Genzyme Corp News

12.5 Isarna Therapeutics GmbH

12.5.1 Company Details

12.5.2 Transforming Growth Factor Beta 1 Product Offered

12.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Isarna Therapeutics GmbH News

12.6 Scholar Rock

12.6.1 Company Details

12.6.2 Transforming Growth Factor Beta 1 Product Offered

12.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Scholar Rock News

12.7 Sirnaomics Inc

12.7.1 Company Details

12.7.2 Transforming Growth Factor Beta 1 Product Offered

12.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 Sirnaomics Inc News

12.8 Eli Lilly and Co

12.8.1 Company Details

12.8.2 Transforming Growth Factor Beta 1 Product Offered

12.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 Eli Lilly and Co News

12.9 Formation Biologics Inc

12.9.1 Company Details

12.9.2 Transforming Growth Factor Beta 1 Product Offered

12.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 Formation Biologics Inc News

12.10 Novartis AG

12.10.1 Company Details

12.10.2 Transforming Growth Factor Beta 1 Product Offered

12.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 Novartis AG News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Transforming Growth Factor Beta 1

Table Product Specifications of Transforming Growth Factor Beta 1

Figure Transforming Growth Factor Beta 1 R